"BioMimetic Therapeutics, Inc. - Product Pipeline Analysis, 2013 Update" Is Now Available at Fast Market Research
BioMimetic Therapeutics, Inc. (BioMimetic), subsidiary of Wright Medical Group, Inc., is a biotechnology company. It develops and commercializes products for the healing of musculoskeletal injuries and diseases which include orthopedics, sports medicine and spine applications. The Augment products are based upon the recombinant human platelet-derived growth factor (rhPDGF-BB) in combination with tissue specific matrices as its primary technology platform for promotion of tissue healing and regeneration. Further, the company's range of products and product candidates combine recombinant protein therapeutics with...
View full press release